An explosion of recent studies from multiple university medical centers recently exposed that the use of the prescription drug Elmiron® can result in patients’ vision failure, up to and including legal blindness. Elmiron® is the brand name for pentosane polysulfate sodium (“PPS”), a drug manufactured and distributed by Janssen Pharmaceuticals. It has been marketed for nearly twenty-five years and resulted in billions of dollars of sales for Janssen. The earliest clinical trials for Elmiron® from the 1990s revealed not only dubious efficacy, but also a hos
With 80 product liability lawsuits already filed and hundreds more likely to follow, lawyers are discussing the coordination of multi-district litigation (MDL). To date, legal action has been taken against Johnson & Johnson’s Janssen Pharmaceuticals Inc., Teva Pharmaceuticals USA Inc., and other pharma companies.
Plaintiffs allege that these companies knowingly withheld risks connected with long-term use of the drug. Complaints list such outcomes as retinal damage and blurred and distorted vision.